Aptus Capital Advisors’s Genesis Healthcare, Inc. GEN Stock Holding History

Aptus Capital Advisors’s Portfolio GEN Stock Details GEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,300	Closed	-$10K	–	477
2020 Q1	$10K	Buy	+12,300	New	+$17.6K	﹤0.01%	362
2019 Q3	–	Sell	-145,990	Closed	-$145K	–	513
2019 Q2	$145K	Buy	+145,990	New	+$186K	0.02%	326

Other funds holding GEN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VCM

V3 Capital Management Dallas, Texas $33.4M AUM 5.9% 1-Year Est. Return

FWC

First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Aptus Capital Advisors's GEN Position: Q2 2020 in Review

Aptus Capital Advisors sold out of Genesis Healthcare, Inc. (GEN) in Q2 2020, closing a stake of 12,300 shares — an estimated $10K sold.

Aptus Capital Advisors first reported a position in GEN in Q2 2019 and held it in 2 quarters. The position peaked at $145K in Q2 2019. 58 funds tracked by Wall St. Rank hold GEN as of Q2 2020.

Aptus Capital Advisors reported no remaining Genesis Healthcare, Inc. position as of Q2 2020 after selling out during the quarter.
Aptus Capital Advisors sold 12,300 Genesis Healthcare, Inc. shares in Q2 2020, an estimated $10K.
Aptus Capital Advisors first reported a position in Genesis Healthcare, Inc. in Q2 2019 and held it in 2 quarters.
Aptus Capital Advisors's Genesis Healthcare, Inc. position peaked at $145K in Q2 2019.
58 funds tracked by Wall St. Rank held Genesis Healthcare, Inc. as of Q2 2020.

Based on Aptus Capital Advisors's 13F filing for Q2 2020, filed 22 Jul 2020.